Sign in

CIK 0001841387

  • Emerging growth company

Candel Therapeutics, Inc.

Sign in to watch
Ticker
CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522214851
Phone
+1 617-916-5445
Business address
117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,160,783
in 1 filing, $3.2M under 10b5-1 plans

Net −$3,160,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tak Paul Peter −$3.2M Chief Executive Officer sold 71% of stake
Date Insider Transaction Shares Price Value Owned after
2026-09-11 Tak Paul Peter Chief Executive Officer Sale 10b5-1 −59,379 $10.46 $621K 113,321
2026-09-10 Tak Paul Peter Chief Executive Officer Exercise or conversion 10b5-1 +125,000 $1.55 $194K 393,566
2026-09-10 Tak Paul Peter Chief Executive Officer Sale 10b5-1 −220,866 $11.50 $2.5M 172,700
2026-09-10 Tak Paul Peter Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −125,000 1,638,968
2026-01-26 Tak Paul Peter Chief Executive Officer Grant or award · Stock Option (Right to Buy) +629,000 629,000
2025-06-25 Tak Paul Peter Chief Executive Officer Grant or award +42,826 $4.67 $200K 268,566
2025-03-19 Tak Paul Peter Chief Executive Officer Sale 10b5-1 −400 $9.00 $4K 225,740
2025-03-18 Tak Paul Peter Chief Executive Officer Sale 10b5-1 −25,772 $8.77 $226K 226,140
2025-02-12 Tak Paul Peter Chief Executive Officer Grant or award · Stock Option (Right to Buy) +525,000 525,000
2025-01-15 Tak Paul Peter Chief Executive Officer Sale −21,704 $7.23 $157K 251,912
2025-01-08 Tak Paul Peter Chief Executive Officer Sale −21,172 $8.22 $174K 273,616
2024-11-29 Tak Paul Peter Chief Executive Officer Sale −48,847 $4.56 $223K 294,788
2024-11-21 Tak Paul Peter Chief Executive Officer Exercise or conversion +12,900 $1.55 $20K 343,635
2024-11-21 Tak Paul Peter Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −12,900 1,763,968
2024-07-17 Tak Paul Peter Chief Executive Officer Sale −22,528 $6.47 $146K 330,735
2024-07-11 Tak Paul Peter Chief Executive Officer Sale −20,293 $5.97 $121K 353,263
2023-11-28 Tak Paul Peter Chief Executive Officer Shares withheld for taxes −43,443 $0.90 $39K 373,556
2023-11-26 Tak Paul Peter Chief Executive Officer Grant or award +180,108 416,999
2023-04-28 Tak Paul Peter Chief Executive Officer Grant or award · Stock Option (Right to Buy) +180,000 180,000
2022-12-09 Tak Paul Peter Chief Executive Officer Purchase +12,935 $1.92 $25K 40,985

Page 1 of 2 · 24 trades